Adhesion G Protein-Coupled Receptors as Drug Targets for Neurological Diseases
Authors:
- 1 April 2019
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 40 (4) , 278-293
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (NS085201, NS094164, NS108446, NS108312)
- National Multiple Sclerosis Society (RG-1501-02577, FG 2063-A1/2)
This publication has 114 references indexed in Scilit:
- The adhesion-GPCR BAI3, a gene linked to psychiatric disorders, regulates dendrite morphogenesis in neuronsMolecular Psychiatry, 2013
- Phosphatidylserine receptor BAI1 and apoptotic cells as new promoters of myoblast fusionNature, 2013
- A novel evolutionarily conserved domain of cell‐adhesion GPCRs mediates autoproteolysisThe EMBO Journal, 2012
- Functional gene group analysis identifies synaptic gene groups as risk factor for schizophreniaMolecular Psychiatry, 2011
- A two-locus genetic interaction between LPHN3 and 11q predicts ADHD severity and long-term outcomeTranslational Psychiatry, 2011
- Genetic Variants at 13q12.12 Are Associated with High Myopia in the Han Chinese PopulationThe American Journal of Human Genetics, 2011
- A cooperative interaction between LPHN3 and 11q doubles the risk for ADHDMolecular Psychiatry, 2011
- Planar polarization in embryonic epidermis orchestrates global asymmetric morphogenesis of hair folliclesNature Cell Biology, 2008
- Hippocampus and Amygdala Morphology in Attention-Deficit/Hyperactivity DisorderArchives of General Psychiatry, 2006
- GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasisProceedings of the National Academy of Sciences, 2006